Member Info for graking

Looks like a merger on the cards

Given that airlines etc can plant trees to offset their carbon emissions, then surely Sandersons next Weald oil planning applications can use a similar argument by proposing their Hydrogen storage plans as the necessary leverage

These enhancements need to have their stated value proven over months. Then new CFC's with these enhancements will recommence subject to low inflation and a buoyant economy. The old factor still remains and that is the number of available trained technicians and manufacturing capacity available at any one time. International licencing will resolve that. China and India must be key locations for such licencing and not beyond the skills of Tesla to take on such a challenge.

Valueplay. The effect of food inflation on profits is the reason new CFC's have slowed down/stopped. Thus the fall in this share price.

Amazon and the like must be salivating to acquire this technology. But where is this in India and China ? Are they too busy copying ?

I can imagine a small queue of interested investors and as this outcome will have been known to SAR during all stages, large pharma or two will already have entered be in the discussion.

15th February RNS. stated inter alia:

"The multiple ascending dose study is ongoing and full safety data from the Phase 1a clinical trial are expected to be available during the first half of 2024. If the results are satisfactory and subject to financing, regulatory requirements, and recruitment preparations, the Company plans to initiate a Phase 1b clinical study. The goal is to recruit up to 24 psoriasis patients, with the study expected to be completed by the end of 2024."

I am assuming the results are now in so should not be too long for an RNS on this outcome.

The usual slide back

If there is a bid soon and guaranteed well paid 5 year contracts for the Directors, plus a loyalty bonus, they would be silly to turn it down. Speculation admittedly but not too uncommon a scenario

The first step will be when the company demerges its technology division from its retailing. The price would rise exponentially merely on the markets assumption that they might be preparing to sell one or both divisions.

Looks like those behind the placings have now made a substantial profit either on paper or otherwise if their modus operandi was a guaranteed cash cow. Those who see this share price now receding to the placing price may just have a point unless and until we have a significant outcome from Australia in this Q2

Of a pending RNS re the Australian experiment may have been premature. On the other hand, any late stage pre-completion findings which are deemed encouraging would cause responsible management to start discussing the future with possible collaborators. That could take time as contract lawyers then get to work and lead to a combined medical and business RNS. Heres hoping

For the Asian rip off trade

Imagine the potential furore if Natwest were to lend money on what some might deem to be favourable terms to Ocado, an Ocado technology customer or even M&S. He had no option but to resign. Pure and simple. Someone making a profit out of this so watch for a share price markup, possibly tomorrow

Imagine a world where dozens of research papers have and are regularly published on any given disease topic going back years Imagine the same world where they are not always translated and because of the historical volumes, no one can read, digest and remember their detailed content. Imagine someone whose brain would allow reading at say 10,000 words per minute with total recall plus an ability to extract critical and related research data. The possibilities are endless. Welcome to AI.

Get the price down, buy up and take a chance the possible good news from Aussy in this first half of the year

Perhaps he is simply hoovering shares to influence the directors to take it private then to sell the patents ie asset stripping

This is a good read https://www.edisongroup.com/research/sdc-1801-embarks-on-clinical-journey-in-fy23/32763/

The Chinese protect their own corporate criminals in exactly the same way. I note that CAP-xx never bothered wasting time in finding Chinese companies busy knocking off their caps designs. That would have been even more expensive.

Multiple fraudulant RNS's. Hope the Australian FCS takes criminal action. All based on outdated capacitors which were copied everywhere. In English law they will now have to stop trading